These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22596268)

  • 21. TOMM40 poly-T variants and cerebrospinal fluid amyloid beta levels in the elderly.
    Pomara N; Bruno D; Nierenberg JJ; Sidtis JJ; Martiniuk FT; Mehta PD; Zetterberg H; Blennow K
    Neurochem Res; 2011 Jun; 36(6):1124-8. PubMed ID: 21455713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects.
    Mise A; Yoshino Y; Yamazaki K; Ozaki Y; Sao T; Yoshida T; Mori T; Mori Y; Ochi S; Iga JI; Ueno SI
    J Alzheimers Dis; 2017; 60(3):1107-1117. PubMed ID: 28984592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamin-binding protein gene on chromosome 10q is associated with late-onset Alzheimer's disease.
    Kuwano R; Miyashita A; Arai H; Asada T; Imagawa M; Shoji M; Higuchi S; Urakami K; Kakita A; Takahashi H; Tsukie T; Toyabe S; Akazawa K; Kanazawa I; Ihara Y;
    Hum Mol Genet; 2006 Jul; 15(13):2170-82. PubMed ID: 16740596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease susceptibility genes APOE and TOMM40, and hippocampal volumes in the Lothian birth cohort 1936.
    Lyall DM; Royle NA; Harris SE; Bastin ME; Maniega SM; Murray C; Lutz MW; Saunders AM; Roses AD; del Valdés Hernández MC; Starr JM; Porteous DJ; Wardlaw JM; Deary IJ
    PLoS One; 2013; 8(11):e80513. PubMed ID: 24260406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants.
    Bruno D; Nierenberg JJ; Ritchie JC; Lutz MW; Pomara N
    Psychoneuroendocrinology; 2012 Mar; 37(3):366-71. PubMed ID: 21803501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
    Patel A; Rees SD; Kelly MA; Bain SC; Barnett AH; Thalitaya D; Prasher VP
    Neurosci Lett; 2011 Jan; 487(2):144-8. PubMed ID: 20946940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levels of cerebrospinal fluid neurofilament light protein in healthy elderly vary as a function of TOMM40 variants.
    Bruno D; Pomara N; Nierenberg J; Ritchie JC; Lutz MW; Zetterberg H; Blennow K
    Exp Gerontol; 2012 May; 47(5):347-52. PubMed ID: 21983493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TOMM40 poly-T variant modulates gene expression and is associated with vocabulary ability and decline in nonpathologic aging.
    Payton A; Sindrewicz P; Pessoa V; Platt H; Horan M; Ollier W; Bubb VJ; Pendleton N; Quinn JP
    Neurobiol Aging; 2016 Mar; 39():217.e1-7. PubMed ID: 26742953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TOMM40 and APOE: Requirements for replication studies of association with age of disease onset and enrichment of a clinical trial.
    Roses AD; Lutz MW; Crenshaw DG; Grossman I; Saunders AM; Gottschalk WK
    Alzheimers Dement; 2013 Mar; 9(2):132-6. PubMed ID: 23333464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implication of sex and SORL1 variants in italian patients with Alzheimer disease.
    Cellini E; Tedde A; Bagnoli S; Pradella S; Piacentini S; Sorbi S; Nacmias B
    Arch Neurol; 2009 Oct; 66(10):1260-6. PubMed ID: 19822782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease.
    Roses AD
    Arch Neurol; 2010 May; 67(5):536-41. PubMed ID: 20457951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TOMM40 '523 Associations with Baseline and Longitudinal Cognition in APOE ɛ3 Homozygotes.
    Watts A; Wilkins HM; Michaelis E; Swerdlow RH
    J Alzheimers Dis; 2019; 70(4):1059-1068. PubMed ID: 31322569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of apolipoprotein E ε4 (ApoE ε4) homozygosity with psychiatric behavioral symptoms.
    Michels A; Multhammer M; Zintl M; Mendoza MC; Klünemann HH
    J Alzheimers Dis; 2012; 28(1):25-32. PubMed ID: 22246233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
    Tolppanen AM; Helisalmi S; Hiltunen M; Kolehmainen M; Schwab U; Pirttilä T; Pulkkinen L; Uusitupa M; Soininen H
    Neurobiol Aging; 2011 Mar; 32(3):546.e7-9. PubMed ID: 19524323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid-β 1-42 levels are modified by apolipoprotein E ε4 in Creutzfeldt-Jakob disease in a similar manner as in Alzheimer's disease.
    Varges D; Jung K; Gawinecka J; Heinemann U; Schmitz M; von Ahsen N; Krasnianski A; Armstrong VW; Zerr I
    J Alzheimers Dis; 2011; 23(4):717-26. PubMed ID: 21157024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation of TOMM40-APOE-APOC2 in Alzheimer's disease.
    Shao Y; Shaw M; Todd K; Khrestian M; D'Aleo G; Barnard PJ; Zahratka J; Pillai J; Yu CE; Keene CD; Leverenz JB; Bekris LM
    J Hum Genet; 2018 Apr; 63(4):459-471. PubMed ID: 29371683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variation at a single locus and age of onset for Alzheimer's disease.
    Lutz MW; Crenshaw DG; Saunders AM; Roses AD
    Alzheimers Dement; 2010 Mar; 6(2):125-31. PubMed ID: 20298972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.